CSI Market
Sign In | Register

Gracell Biotechnologies Inc (GRCL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GRCL Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Gracell Biotechnologies Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GRCL/balance-sheets
https://api.csimarket.com/api/v1/companies/GRCL/fundamentals
https://api.csimarket.com/api/v1/companies/GRCL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2023)
(Dec 31 2022) 0 0 0
Assets
Cash & cash equivalent163.34
Short-term Investments, Total0.49
Cash & Short-term Investments163.00
Notes Receivable, Current4.94
Inventories0.23
Derivatives, Collateral, Regulatory, Deferred0.00
Prepaid Expense And Other Assets Current8.19
Total Current Assets172.03
Equipment/Property/Plant Net21.80
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.70
Other Assets, Noncurrent0.00
Total Assets190.02
Liabilities
Accrued Liabilities And Other Liabilities10.42
Short-term Debt14.21
Other Liabilities, Current0.26
Total Current Liabilities26.73
Long-term debt19.72
Total Long-term Debt19.72
Other liabilities, Noncurrent1.02
Total Liabilities33.26
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock405.77
Retained Earnings / Accumulated Deficit-265.32
Accumulated Other Comprehensive Income16.29
Other Equity16.29
Common Stockholder's Equity156.76
Total Stockholder's Equity156.76
Liabilities & Stockholder's Equity190.02
4 historic quarters locked

Sign in to unlock the full Gracell Biotechnologies Inc balance sheet history.

Sign In Create Free Account

About Gracell Biotechnologies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-23-049599

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI